II

Iram Ismail

Active Director Director DIN 07669709
DIN 07669709 First appointment Nov 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value •••• Premium profile

About Iram Ismail

Data last updated:

Iram Ismail is a Director at Module Pharmaceutical Private Limited (since 2016). The company operates in Pharma. Module Pharmaceutical Private Limited reported revenue of ₹87.1 Lakh (FY 2025).

DIN 07669709
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2016
Oldest Company Age 14 yrs
Largest company Module Pharmaceutical Private Limited · ₹87.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20162012₹87.1 Lakh (FY 2025)Active

Board colleagues of Iram Ismail

NameDINCompanyDesignation
Shahabuddin Khan05187291Module Pharmaceutical Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Module Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Iram Ismail

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iram Ismail

Iram Ismail currently holds 1 directorship: Module Pharmaceutical Private Limited (Director, since 21 Nov 2016, revenue ₹87.1 Lakh (FY 2025)).

Iram Ismail was first appointed on 21 Nov 2016 as Director at Module Pharmaceutical Private Limited.

The current boards of Iram Ismail's companies include Shahabuddin Khan (Module Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available